Chemoinformaics analysis of 9-Hydroxy-Alpha-Lapachone
| Molecular Weight | 258.273 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 16 |
| Exact Molecular Weight | 258.089 | nRing | 3 |
| Solubility: LogS | -3.225 | nHRing | 1 |
| Solubility: LogP | 4.155 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 37.5931 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.635 |
| Synth | 2.95 |
| Natural Product Likeliness | 2.625 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0 |
| HIA | 0.022 |
| CACO-2 | -4.884 |
| MDCK | 0.0000235 |
| BBB | 0.032 |
| PPB | 0.998608 |
| VDSS | 0.474 |
| FU | 0.0238304 |
| CYP1A2-inh | 0.946 |
| CYP1A2-sub | 0.624 |
| CYP2c19-inh | 0.177 |
| CYP2c19-sub | 0.113 |
| CYP2c9-inh | 0.647 |
| CYP2c9-sub | 0.819 |
| CYP2d6-inh | 0.789 |
| CYP2d6-sub | 0.336 |
| CYP3a4-inh | 0.376 |
| CYP3a4-sub | 0.163 |
| CL | 3.735 |
| T12 | 0.614 |
| hERG | 0.011 |
| Ames | 0.224 |
| ROA | 0.665 |
| SkinSen | 0.922 |
| Carcinogencity | 0.812 |
| EI | 0.869 |
| Respiratory | 0.551 |
| NR-Aromatase | 0.366 |
| Antiviral | No |
| Prediction | 0.584817 |